National expansion Tomo Drug Testing operates with multiple office locations and onsite testing across Missouri, Indiana, Nevada, Oklahoma, and surrounding states, indicating opportunities to expand outreach and cross-sell services to regional and national clients with multi-state compliance needs.

Acquisition momentum Recent acquisitions of Knox Laboratory and Drug and Alcohol Testing, LLC suggest a growth strategy that may open doors for bundled services, expanded capabilities, and cross-sell opportunities to clients of those acquired entities.

Leadership continuity Promotions of senior leaders to Vice President of Operations and President within the last few years signal a stable leadership team focused on scaling operations and potentially more decisive vendor and enterprise client engagements.

Financial scale With reported revenue in the range of 50 to 100 million, Tomo Drug Testing is a mid-market player likely seeking enterprise customers with large-volume testing needs, presenting a compelling target for long-term contracts and managed services deals.

Industry positioning As a long-standing player in compliance-driven drug and alcohol testing serving companies, schools, and organizations, Tomo presents opportunities to upsell integrated HR compliance solutions, digital testing platforms, and analytics to improve safety, risk management, and workforce screening.